Ph I/II Study of Allogeneic SCT for Clinically Aggressive Sickle Cell Disease (SCD)
Clinical trial NCT01499888 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01499888
- Sponsor
- University of Illinois at Chicago
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-11
- Primary completion
- 2028-09-23
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.